Analysis, guides and explainers on India's unlisted market — from IPO pipelines to ESOP liquidity.
<h2>A) Who is Deep Algorithm Solutions?</h2> <p>Deep Algorithm Solutions, founded in 2021 and headquartered in India, is a B2B SaaS company focused on cybersecurity and fraud prevention. It serves high-risk industries such as BFSI, fintech, healthcare, and government with AI-driven solutions. The company is dedicated to building predictive, behavior-based protection systems that proactively secure digital identities.</p> <h2>B) How Much Funding Did They Raise and Who Invested?</h2> <p><strong>Funding Stage:</strong> Seed Round<br /><strong>Total Amount Raised:</strong> ₹10.8 crore (~$1.25 million)<br /><strong>Lead Investor:</strong> Unicorn India Ventures<br /><strong>Other Backers:</strong> Prominent angel investors</p> <h2>C) How Will the Funds Be Utilized?</h2> <p>The seed capital will be strategically allocated to:</p> <ul data-spread="false"> <li> <p>Scale engineering and threat intelligence teams</p> </li> <li> <p>Expand Go-To-Market (GTM) strategies across India and Southeast Asia</p> </li> <li> <p>Strengthen integrations with platforms like <strong>Azure Active Directory</strong> and <strong>Okta</strong></p> </li> <li> <p>Upgrade the AI-driven fraud analytics and behavioral intelligence engine</p> </li> </ul> <h2>D) What Are the Core Products Offered by Deep Algorithm?</h2> <p>Deep Algorithm offers two flagship AI-powered cybersecurity tools:</p> <h3>1. <strong>adapIDAI</strong></h3> <p>An identity security platform that leverages <strong>behavioral intelligence</strong> to detect anomalies and threats in real time.</p> <h3>2. <strong>BotShield</strong></h3> <p>A comprehensive threat defense suite designed to:</p> <ul data-spread="false"> <li> <p>Prevent zero-day attacks</p> </li> <li> <p>Mitigate Distributed Denial of Service (DDoS) attacks</p> </li> <li> <p>Secure runtime applications in critical environments</p> </li> </ul> <h2>E) Where Have These Solutions Been Deployed?</h2> <p><strong>Live Deployments:</strong></p> <ul data-spread="false"> <li> <p>A major private bank</p> </li> <li> <p>A central government entity</p> </li> <li> <p>A private multi-specialty hospital</p> </li> </ul> <p><strong>Ongoing Discussions:</strong></p> <ul data-spread="false"> <li> <p>Several Indian banks and fintech companies</p> </li> </ul> <p><strong>IP Portfolio:</strong></p> <ul data-spread="false"> <li> <p>1 Indian patent granted</p> </li> <li> <p>1 international patent filed</p> </li> </ul> <h2>F) What is Their Expansion Strategy?</h2> <h3>🇮🇳 Domestic Expansion:</h3> <ul data-spread="false"> <li> <p>Strengthening their footprint in India’s key BFSI hubs like <strong>Mumbai</strong> and <strong>Bengaluru</strong></p> </li> </ul> <h3>🌐 International Outreach:</h3> <ul data-spread="false"> <li> <p>Building partnerships in <strong>Kenya</strong>, <strong>South Africa</strong>, and the <strong>UAE</strong></p> </li> </ul> <h3>🤝 Channel Development:</h3> <ul data-spread="false"> <li> <p>Collaborating with system integrators</p> </li> <li> <p>Getting listed on major <strong>cloud marketplaces</strong> to widen enterprise adoption</p> </li> </ul> <h2>G) What’s on the Roadmap for the Next 12–18 Months?</h2> <ul data-spread="false"> <li> <p>Launch of scalable <strong>SaaS-based solutions</strong> for mid-market clients</p> </li> <li> <p>Expansion into <strong>two or more international markets</strong></p> </li> <li> <p>Rollout of a <strong>fraud analytics dashboard</strong> for enterprise risk teams</p> </li> <li> <p>R&D into <strong>agentic AI</strong> for autonomous fraud resolution</p> </li> </ul> <h2>H) What Are the Leadership and Investors Saying?</h2> <p><strong>JP Mishra</strong>, CEO – <em>"Our vision is to redefine digital identity protection using indigenous AI technologies, making fraud prevention more predictive and less reactive."</em></p> <p><strong>Anil Joshi</strong>, Managing Partner at Unicorn India Ventures – <em>"The demand for cybersecurity is intensifying, particularly in the BFSI sector. Deep Algorithm’s AI-led platform is uniquely positioned to address these risks at scale."</em></p> <h2>I) What’s the UnlistedZone Take on Deep Algorithm’s Future?</h2> <p>With its <strong>patent-backed AI platforms</strong>, early traction across high-risk sectors, and clear SaaS roadmap, Deep Algorithm is quickly emerging as a <strong>credible force in enterprise cybersecurity</strong>. Their strategic mix of <strong>domestic consolidation</strong>, <strong>global expansion</strong>, and <strong>agentic AI innovation</strong> positions them strongly for long-term success.</p> <h2>J) What Are the Key Takeaways?</h2> <ul data-spread="false"> <li> <p>Raised ₹10.8 crore in seed funding, led by Unicorn India Ventures</p> </li> <li> <p> Strong early traction in BFSI, healthcare, and government verticals</p> </li> <li> <p> SaaS rollout and global entry planned over the next year</p> </li> <li> <p> R&D focused on behavioral intelligence and autonomous AI fraud solutions</p> </li> </ul> <div><hr /></div> <p><strong>Stay tuned with UnlistedZone for more updates on India’s fast-growing tech startups and funding news.</strong></p> <div><hr /></div> <h3>📌 Disclaimer</h3> <p>UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor. All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice. Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility. UnlistedZone does not guarantee any returns and shall not be held liable for any losses incurred as a result of investment decisions taken based on the information provided.</p>
<p data-pm-slice="1 1 []">Care Health Insurance (formerly <strong>Religare Health Insurance</strong>) has emerged as one of India’s fastest-growing standalone health insurers. Despite robust topline growth in FY25, the company faced a steep drop in profitability, reflecting critical insights for investors tracking the unlisted market.</p> <hr /> <h2>A) Company Overview</h2> <ul data-spread="false"> <li> <p><strong>Parent Company</strong>: Religare Enterprises Limited</p> </li> <li> <p><strong>Established</strong>: 2012</p> </li> <li> <p><strong>Regulated by</strong>: IRDAI (Insurance Regulatory and Development Authority of India)</p> </li> <li> <p><strong>Key Stakeholders</strong>:</p> <ul data-spread="false"> <li> <p>Religare Enterprises Limited(∼62%)</p> </li> <li> <p>Union Bank of India(5.83%)</p> </li> <li> <p>Trishikhar Ventures (∼15%)</p> </li> </ul> </li> </ul> <p>Care Health Insurance offers a comprehensive range of <strong>retail and corporate health insurance products</strong> and has built a nationwide presence through banks, agents, and digital platforms.</p> <div><hr /></div> <h2> B) Business Model of Care Health Insurance </h2> <p>Care Health operates on a <strong>risk pooling model</strong>, where it collects premiums upfront and pays claims when required. Understanding the health insurance business involves breaking down the premium collection, risk sharing, and expense structure. Here's how it works:</p> <h3>Step-by-Step Understanding:</h3> <ol start="1" data-spread="true"> <li> <p><strong>Policy Sales and Gross Written Premium (GWP)</strong>:</p> <ul data-spread="false"> <li> <p>Suppose Care Health sells <strong>10,000 policies</strong> in FY25.</p> </li> <li> <p>Assume each policy has an <strong>average premium of ₹15,000</strong>.</p> </li> <li> <p>So, <strong>GWP = 10,000 × 15,000 = ₹15 crore</strong>.</p> </li> </ul> </li> <li> <p><strong>Reinsurance</strong>:</p> <ul data-spread="false"> <li> <p>Insurance companies offload part of their risk to reinsurers.</p> </li> <li> <p>If Care Health cedes ₹5 crore to a reinsurer,</p> </li> <li> <p><strong>Net Written Premium (NWP) = ₹15 crore - ₹5 crore = ₹10 crore</strong>.</p> </li> </ul> </li> <li> <p><strong>Premium Recognition - Net Earned Premium (NEP)</strong>:</p> <ul data-spread="false"> <li> <p>Policies sold are not entirely recognized in the same year due to accounting norms.</p> </li> <li> <p>Suppose:</p> <ul data-spread="false"> <li> <p>5,000 policies sold in April,</p> </li> <li> <p>3,000 in September,</p> </li> <li> <p>2,000 in October,</p> </li> </ul> </li> <li> <p>Only part of the premium is recognized in FY25.</p> </li> <li> <p>Hence, <strong>NEP = Portion of NWP recognized based on policy tenure</strong>.</p> </li> </ul> </li> <li> <p><strong>Expenses</strong>:</p> <ul data-spread="false"> <li> <p><strong>Operating Expenses</strong>: Rent, salaries, admin costs.</p> </li> <li> <p><strong>Commission</strong>: Agents/distributors earn commission per policy.</p> </li> <li> <p><strong>Claims</strong>: Payments made when policyholders raise claims.</p> </li> </ul> </li> <li> <p><strong>Operating Profit</strong>:</p> <ul data-spread="false"> <li> <p><strong>NEP - Claims - Commission - Operating Expenses = Operating Profit</strong></p> </li> </ul> </li> <li> <p><strong>Investment Income</strong>:</p> <ul data-spread="false"> <li> <p>Insurers invest collected premiums in debt/equity instruments.</p> </li> <li> <p>The <strong>return from these investments adds to overall income</strong>.</p> </li> </ul> </li> <li> <p><strong>Total Income = Operating Profit + Investment Income</strong></p> </li> <li> <p><strong>Profit After Tax (PAT)</strong>:</p> <ul data-spread="false"> <li> <p>After tax outflow, the remaining profit is <strong>PAT</strong>.</p> </li> </ul> </li> </ol> <h3>Key Ratios to Track:</h3> <ul data-spread="true"> <li> <p><strong>Loss Ratio</strong> = Claims Incurred / Net Earned Premium</p> <ul data-spread="false"> <li> <p>Indicates the proportion of earned premium used to pay claims.</p> </li> <li> <p>Lower ratio = better underwriting performance.</p> </li> </ul> </li> <li> <p><strong>Combined Ratio</strong> = (Claims + Commission + Operating Expenses) / NEP</p> <ul data-spread="false"> <li> <p>If this ratio < 100%, the company is making underwriting profits.</p> </li> <li> <p>If > 100%, underwriting operations are in loss.</p> </li> </ul> </li> </ul> <div><hr /></div> <h2>C) Revenue Model: How Care Health Earns Money? </h2> <ol start="1" data-spread="false"> <li> <p><strong>Gross Written Premium (GWP)</strong>: This is the primary income source. Care Health’s GWP grew 21% YoY in FY25 to ₹8,318 Cr.</p> </li> <li> <p><strong>Net Earned Premium (NEP)</strong>: After reinsurance adjustments, NEP stood at ₹6,733 Cr in FY25.</p> </li> <li> <p><strong>Investment Income</strong>: Income from shareholder and policyholder funds (₹368 Cr in FY25).</p> </li> <li> <p><strong>Other Revenue</strong>: Minor inflow from auxiliary sources, which sharply declined in FY25.</p> </li> </ol> <div><hr /></div> <h2>D) Financial Overview (FY22–FY25)</h2> <h3>1. Premium & Revenue Trends (₹ Cr)</h3> <table> <tbody> <tr> <th style="text-align: center;">Metric</th> <th style="text-align: center;">FY22</th> <th style="text-align: center;">FY23</th> <th style="text-align: center;">FY24</th> <th style="text-align: center;">FY25</th> </tr> <tr> <td style="text-align: center;">Gross Written Premium</td> <td style="text-align: center;">3,880</td> <td style="text-align: center;">5,141</td> <td style="text-align: center;">6,864</td> <td style="text-align: center;">8,318</td> </tr> <tr> <td style="text-align: center;">Net Earned Premium</td> <td style="text-align: center;">3,088</td> <td style="text-align: center;">4,590</td> <td style="text-align: center;">6,047</td> <td style="text-align: center;">6,733</td> </tr> <tr> <td style="text-align: center;">Total Revenue</td> <td style="text-align: center;">2,962</td> <td style="text-align: center;">4,525</td> <td style="text-align: center;">5,678</td> <td style="text-align: center;">6,724</td> </tr> </tbody> </table> <div><hr /></div> <h2> 2. Profitability: Rising Costs Impact Margins</h2> <table> <tbody> <tr> <td style="text-align: center;">Metric</td> <td style="text-align: center;">FY24</td> <td style="text-align: center;">FY25</td> <td style="text-align: center;">YoY Change</td> </tr> <tr> <td style="text-align: center;">PAT</td> <td style="text-align: center;">₹305 Cr</td> <td style="text-align: center;">₹155 Cr</td> <td style="text-align: center;">▼ 49%</td> </tr> <tr> <td style="text-align: center;">EPS</td> <td style="text-align: center;">₹3.14</td> <td style="text-align: center;">₹1.59</td> <td style="text-align: center;">▼ 49%</td> </tr> <tr> <td style="text-align: center;">Claims Incurred</td> <td style="text-align: center;">₹3,074 Cr</td> <td style="text-align: center;">₹4,096 Cr</td> <td style="text-align: center;">▲ 33%</td> </tr> <tr> <td style="text-align: center;">Commission Expense</td> <td style="text-align: center;">₹1,070 Cr</td> <td style="text-align: center;">₹1,357 Cr</td> <td style="text-align: center;">▲ 27%</td> </tr> <tr> <td style="text-align: center;">Operating Profit</td> <td style="text-align: center;">₹356 Cr</td> <td style="text-align: center;">₹49 Cr</td> <td style="text-align: center;">▼ 86%</td> </tr> </tbody> </table> <h3>Key Challenges:</h3> <ul data-spread="false"> <li> <p>Claims rose faster than premium (↑33% vs ↑21%).</p> </li> <li> <p>Surge in commissions driven by aggressive distribution strategy.</p> </li> <li> <p>Fall in auxiliary income.</p> </li> <li> <p>Margins squeezed despite growing topline.</p> </li> </ul> <div><hr /></div> <h2>3. Balance Sheet Strength (₹ Cr)</h2> <table> <tbody> <tr> <td style="text-align: center;">Metric</td> <td style="text-align: center;">FY22</td> <td style="text-align: center;">FY23</td> <td style="text-align: center;">FY24</td> <td style="text-align: center;">FY25</td> </tr> <tr> <td style="text-align: center;">Total Assets</td> <td style="text-align: center;">3,987</td> <td style="text-align: center;">5,514</td> <td style="text-align: center;">7,112</td> <td style="text-align: center;">8,976</td> </tr> <tr> <td style="text-align: center;">Investments (Shareholder+Policyholder)</td> <td style="text-align: center;">3,565</td> <td style="text-align: center;">5,076</td> <td style="text-align: center;">6,632</td> <td style="text-align: center;">8,399</td> </tr> <tr> <td style="text-align: center;">Reserves & Surplus</td> <td style="text-align: center;">380</td> <td style="text-align: center;">806</td> <td style="text-align: center;">1,198</td> <td style="text-align: center;">1,399</td> </tr> <tr> <td style="text-align: center;">Current Liabilities</td> <td style="text-align: center;">1,161</td> <td style="text-align: center;">1,559</td> <td style="text-align: center;">2,002</td> <td style="text-align: center;">3,343</td> </tr> </tbody> </table> <p>✅ <strong>Strengths</strong>:</p> <ul data-spread="false"> <li> <p>Steady rise in assets and investment base.</p> </li> <li> <p>Shareholder investments grew to ₹2466 Cr.</p> </li> <li> <p>Sufficient reserves & surplus of ₹1,399 Cr.</p> </li> </ul> <p>⚠️ <strong>Concerns</strong>:</p> <ul data-spread="false"> <li> <p>Current liabilities rose 67% YoY, indicating short-term stress.</p> </li> <li> <p>High provisioning due to claims exposure.</p> </li> </ul> <div><hr /></div> <h2>4. Cash Flow Position</h2> <table> <tbody> <tr> <td style="text-align: center;">Metric</td> <td style="text-align: center;">FY22</td> <td style="text-align: center;">FY23</td> <td style="text-align: center;">FY24</td> <td style="text-align: center;">FY25</td> </tr> <tr> <td style="text-align: center;">CFO (Operating)</td> <td style="text-align: center;">₹667 Cr</td> <td style="text-align: center;">₹1,031 Cr</td> <td style="text-align: center;">₹1,048 Cr</td> <td style="text-align: center;">₹1,377 Cr</td> </tr> <tr> <td style="text-align: center;">CFI (Investing)</td> <td style="text-align: center;">-₹787 Cr</td> <td style="text-align: center;">-₹1,307 Cr</td> <td style="text-align: center;">-₹1,168 Cr</td> <td style="text-align: center;">-₹1,286 Cr</td> </tr> <tr> <td style="text-align: center;">Net Cash at Year-End</td> <td style="text-align: center;">₹78 Cr</td> <td style="text-align: center;">₹99 Cr</td> <td style="text-align: center;">₹96 Cr</td> <td style="text-align: center;">₹194 Cr</td> </tr> </tbody> </table> <p>Care Health managed to maintain <strong>positive operational cash flows</strong> despite falling profits. The cash balance doubled to ₹194 Cr in FY25, supported by strong premium collections.</p> <div><hr /></div> <h2>E) Stock Performance in Unlisted Market</h2> <h3>1. Share Price Trend (2021–2025) - Under Performer in the Unlisted Market</h3> <table> <tbody> <tr> <td style="text-align: center;">Timeframe</td> <td style="text-align: center;">Peak Price</td> <td style="text-align: center;">Current Price (Jul 2025)</td> <td style="text-align: center;">% Fall</td> </tr> <tr> <td style="text-align: center;">2021–22</td> <td style="text-align: center;">₹270</td> <td style="text-align: center;">₹162</td> <td style="text-align: center;">▼ 40%</td> </tr> </tbody> </table> <ul data-spread="false"> <li> <p><strong>Current Price</strong>: ₹162</p> </li> <li> <p><strong>P/E Ratio</strong>: 101.89</p> </li> <li> <p><strong>P/B Ratio</strong>: 6.65</p> </li> <li> <p><strong>ROE</strong>: 6.53%</p> </li> <li> <p><strong>MCap / GWP</strong>: 1.93x</p> </li> </ul> <h3>2. Valuation Insights</h3> <p>The sharp fall in share price is driven by:</p> <ul data-spread="false"> <li> <p>Declining profitability and EPS halving in FY25.</p> </li> <li> <p>Market sentiment turning negative for unlisted insurers.</p> </li> <li> <p>However, the last quarter of FY25 was profitable indicating that if they continue to perform well, FY26 could be good year for them. On that basis valuation could be reasonable at CMP based on Mcap/GWP metrics. </p> </li> </ul> <div><hr /></div> <h2>F) Comparative Financial Performance (FY25) of Health Insurers</h2> <p>(All figures in ₹ crore unless specified)</p> <table> <tbody> <tr> <td style="text-align: center;">Particulars</td> <td style="text-align: center;">Care Health</td> <td style="text-align: center;">Niva Bupa</td> <td style="text-align: center;">Star Health</td> </tr> <tr> <td style="text-align: center;">Gross Written Premium</td> <td style="text-align: center;">8,318</td> <td style="text-align: center;">6,762</td> <td style="text-align: center;">16,781</td> </tr> <tr> <td style="text-align: center;">Claims Incurred</td> <td style="text-align: center;">4,096</td> <td style="text-align: center;">2,997</td> <td style="text-align: center;">10,420</td> </tr> <tr> <td style="text-align: center;">Commission Paid</td> <td style="text-align: center;">1,357</td> <td style="text-align: center;">1,065</td> <td style="text-align: center;">2,241</td> </tr> <tr> <td style="text-align: center;">Profit After Tax (PAT)</td> <td style="text-align: center;">155</td> <td style="text-align: center;">214</td> <td style="text-align: center;">646</td> </tr> <tr> <td style="text-align: center;">Combined Ratio</td> <td style="text-align: center;">103%</td> <td style="text-align: center;">101.2%</td> <td style="text-align: center;">101.09%</td> </tr> <tr> <td style="text-align: center;">Net Loss Ratio</td> <td style="text-align: center;">64.5%</td> <td style="text-align: center;">61.2%</td> <td style="text-align: center;">70.3%</td> </tr> <tr> <td style="text-align: center;">Mcap/GWP (Multiple)</td> <td style="text-align: center;">1.92x</td> <td style="text-align: center;">2.42x</td> <td style="text-align: center;">1.53x</td> </tr> </tbody> </table> <h3>Key Insights:</h3> <p><strong>Market Position:</strong></p> <ul data-spread="false"> <li> <p>Star Health dominates in GWP (₹16,781cr), nearly 2x Care Health and 2.5x Niva Bupa.</p> </li> <li> <p>Care Health has higher claims and commissions than Niva Bupa but trails Star Health.</p> </li> </ul> <p><strong>Profitability:</strong></p> <ul data-spread="false"> <li> <p>Star Health leads in PAT (₹646cr), followed by Niva Bupa (₹214cr) and Care Health (₹155cr).</p> </li> <li> <p>Combined Ratios: All insurers are near breakeven (100-103%), with Star Health being most efficient (101.09%).</p> </li> </ul> <p><strong>Underwriting Efficiency:</strong></p> <ul data-spread="false"> <li> <p>Net Loss Ratio: Niva Bupa is most efficient (61.2%), while Star Health has the highest claims burden (70.3%).</p> </li> </ul> <p><strong>Valuation (Mcap/GWP):</strong></p> <ul data-spread="false"> <li> <p>Niva Bupa trades at the highest multiple (2.42x), suggesting stronger investor confidence.</p> </li> <li> <p>Star Health has the lowest multiple (1.53x) despite its scale, possibly due to higher claims.</p> </li> </ul> <div><hr /></div> <h2>Conclusion</h2> <p>Care Health Insurance is a <strong>high-growth health insurer</strong> that has struggled with cost control and margin preservation in FY25. While the topline is strong, the <strong>profitability squeeze, high commissions, and rising claims</strong> are red flags for investors.</p> <p>However, with a solid asset base, growing cash reserves, and strong policyholder trust, a strategic pivot toward cost optimization could reignite long-term value.</p> <h3> Final Take for Unlisted Investors:</h3> <ul data-spread="false"> <li> <p><strong>Strengths</strong>: Care Health boasts strong premium growth, a recognized brand, and a healthy investment portfolio that has steadily increased over the years.</p> </li> <li> <p><strong>Challenges</strong>: The company currently faces margin pressures due to high claims, rising commissions, and a sharp decline in profitability. However, last quarter of Fy25 was profitable. </p> </li> <li> <p><strong>Investment Outlook</strong>: While the long-term fundamentals remain promising, short-term headwinds suggest a cautious approach. Investors should closely monitor margin recovery and claim containment before accumulating at the current price band of ₹160–₹180.</p> </li> </ul> <p>👉 <em>If you want to know more about Care Health Insurance, visit:</em> <a href="https://unlistedzone.com/shares/care-health-previously-religare-health-insurance-company-limited-unlisted-shares-buy-sell-share-price/">UnlistedZone Care Health Page</a></p> <div><hr /></div> <h2>⚠️ Disclaimer</h2> <p>UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor. All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice. Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility. UnlistedZone does not guarantee any returns and shall not be held liable for any losses incurred as a result of investment decisions taken based on the information provided.</p>
<p>Navana.ai, a pioneering Voice AI startup founded in 2018 by brothers Raoul and Jai Nanavati, has successfully raised ₹7 crore in a <strong>Pre-Series A round</strong> led by <strong>Antler India</strong>. With this round, the company’s <strong>total funding now stands at ₹13.2 crore</strong>.</p> <h3>A) Who Are the Investors Backing Navana.ai?</h3> <p>This recent round saw participation from marquee investors including:</p> <ul data-spread="false"> <li> <p><strong>Ajay Agarwal</strong></p> </li> <li> <p><strong>Ronnie Screwvala</strong></p> </li> <li> <p><strong>Sandeep Singhal</strong> (who also led their previous angel round via Nexus Ventures)</p> </li> </ul> <p>Navana.ai’s earlier <strong>₹6.2 crore angel round</strong> included notable backers such as:</p> <ul data-spread="false"> <li> <p><strong>Stanford Angel Fund</strong></p> </li> <li> <p><strong>Rajan Mehra</strong></p> </li> <li> <p><strong>Saahil Goel</strong></p> </li> </ul> <h3>B) What Does Navana.ai Offer?</h3> <p>Navana.ai specializes in <strong>Voice AI solutions</strong> crafted for Indian enterprises, particularly within the <strong>BFSI (Banking, Financial Services, and Insurance)</strong> sector.</p> <h3>C) What Is Included in Navana.ai’s Product Suite?</h3> <p>Their solutions are designed for India's multilingual landscape and include:</p> <ul data-spread="false"> <li> <p><strong>Voice AI Contact Centre</strong></p> </li> <li> <p><strong>Speech Recognition API</strong></p> </li> <li> <p><strong>Contact Centre Intelligence API</strong></p> </li> </ul> <p>These tools currently support <strong>12+ Indian languages</strong>, allowing enterprises to engage customers ranging from <strong>urban English speakers to rural dialect users</strong>.</p> <h3>D) How Will the Funds Be Utilized?</h3> <p>Navana.ai plans to channel the newly raised capital toward:</p> <ul data-spread="false"> <li> <p>Strengthening its <strong>R&D efforts</strong></p> </li> <li> <p>Accelerating <strong>deployment of products</strong> across enterprise clients</p> </li> <li> <p>Developing a robust <strong>India-centric language AI stack</strong></p> </li> </ul> <h3>E) What Is the Reach and Impact of Navana.ai So Far?</h3> <p>The company already serves <strong>40+ enterprises</strong>, including notable names like <strong>Bajaj Finserv</strong>. Their technology has proven valuable in enhancing both <strong>customer experience</strong> and <strong>operational efficiency</strong> across large-scale enterprises.</p> <h3>F) Why Is Navana.ai’s Growth Important?</h3> <p>As India embraces digital transformation, the need for <strong>context-aware, multilingual AI solutions</strong> is greater than ever. Navana.ai is uniquely positioned to capture this demand with its localized approach to voice technology.</p> <p>Stay tuned with <strong>UnlistedZone</strong> for the latest on India’s most promising startups, funding updates, and developments in the unlisted space.</p> <h3>Disclaimer:</h3> <p>UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor.All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice.Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility.UnlistedZone does not guarantee any returns and shall not be held liable for any losses incurred as a result of investment decisions taken based on the information provided.</p>
<h2 data-pm-slice="1 1 []">A)Business Overview</h2> <p>Dalmia Bharat Refractories Ltd. (DBRL) continued its strategic journey in FY 2024–25 with a dual focus on:</p> <ul data-spread="false"> <li> <p>Strengthening its <strong>core magnesia carbon refractory business</strong></p> </li> <li> <p>Reviving the newly acquired <strong>tyre business</strong> of Birla Tyre through CIRP (in partnership with Himadri Specialty Chemicals)</p> </li> </ul> <p>Despite operational challenges, DBRL has shown resilience and aims to capitalize on industry tailwinds across steel, automotive, and infrastructure sectors.</p> <div><hr /></div> <h2>B) Financial Highlights (Consolidated)</h2> <table> <tbody> <tr> <th>Particulars</th> <th>FY 2024–25</th> <th>FY 2023–24</th> <th>% Change</th> </tr> <tr> <td>Revenue from Continuing Operations</td> <td>₹199.37 Cr</td> <td>₹179.04 Cr</td> <td><strong>+11.34%</strong></td> </tr> <tr> <td>EBITDA from Continuing Operations</td> <td>₹73.06 Cr</td> <td>₹35.67 Cr</td> <td><strong>+104.88%</strong></td> </tr> </tbody> </table> <blockquote> <p>📌 <strong>EBITDA margin improvement</strong> reflects better cost management, operating efficiency, and possibly higher margin mix from mag-carbon exports.</p> </blockquote> <div><hr /></div> <h2>C) Key Business Developments</h2> <h3>1️⃣ <strong>Magnesia Carbon Refractories (Core Business)</strong></h3> <ul data-spread="false"> <li> <p>Focused investment and production at <strong>Salem plant</strong> aligns with “Make in India” vision.</p> </li> <li> <p><strong>Global subsidiaries</strong> (OCL Global & OCL China) ensured uninterrupted service to international clients.</p> </li> <li> <p>Global outlook remains favorable with increasing demand from:</p> <ul data-spread="false"> <li> <p>Steel production via <strong>Electric Arc Furnaces (EAF)</strong></p> </li> <li> <p>Advancements in <strong>eco-friendly</strong> and <strong>nano-carbon refractory technologies</strong></p> </li> </ul> </li> <li> <p><strong>Risks</strong> remain from raw material volatility and price competition.</p> </li> </ul> <h3>2️⃣ <strong>Tyre Business Revival</strong></h3> <ul data-spread="false"> <li> <p>Acquired through <strong>Insolvency Process</strong> jointly with Himadri Specialty Chemical.</p> </li> <li> <p>Revival efforts included:</p> <ul data-spread="false"> <li> <p>Upgrading production infrastructure</p> </li> <li> <p>Building leadership and workforce alignment</p> </li> </ul> </li> <li> <p><strong>Labour unrest</strong> at manufacturing facilities slowed progress.</p> </li> <li> <p>Company is adopting <strong>structured dialogue mechanisms</strong> to build long-term workforce stability.</p> </li> </ul> <h3>3️⃣ <strong>Proposed Acquisitions</strong></h3> <ul data-spread="false"> <li> <p>Progress made toward acquiring <strong>Dalmia Magnesite Corporation</strong> and <strong>Govan Travels</strong> (divisions of Dalmia Bharat Sugar).</p> </li> <li> <p>Deal pending <strong>NCLT approval</strong>; expected to strengthen DBRL’s asset base and diversify operations.</p> </li> </ul> <div><hr /></div> <h2>D) Industry Tailwinds</h2> <h3> Refractory Market:</h3> <ul data-spread="false"> <li> <p>Technavio projects steady global growth till 2028.</p> </li> <li> <p>Key growth drivers:</p> <ul data-spread="false"> <li> <p>Eco-friendly refractories</p> </li> <li> <p>Rise in EAF steel manufacturing</p> </li> <li> <p>Nano-carbon advancements</p> </li> </ul> </li> </ul> <h3>Tyre Market:</h3> <ul data-spread="false"> <li> <p>Global market to cross <strong>$250 Bn by 2026</strong> (Statista)</p> </li> <li> <p>India is the <strong>2nd largest 2W tyre producer</strong>; poised for strong growth in:</p> <ul data-spread="false"> <li> <p><strong>Replacement cycle</strong></p> </li> <li> <p><strong>EV-compatible tyres</strong></p> </li> <li> <p><strong>Low-rolling-resistance</strong> segment (due to sustainability push)</p> </li> </ul> </li> </ul> <div><hr /></div> <h2>F) UnlistedZone View</h2> <p>DBRL is positioning itself as a <strong>diversified industrial play</strong> spanning high-growth verticals — <strong>refractories and tyres</strong>. Key positives include:</p> <ul data-spread="false"> <li> <p>Strong operating leverage visible from EBITDA growth</p> </li> <li> <p>Strategic alignment with EV and green steel themes</p> </li> <li> <p>Focused revival and expansion strategy</p> </li> </ul> <p>However, the <strong>execution risks</strong> in the tyre business and <strong>competition in refractories</strong> require close monitoring.</p> <div><hr /></div> <h2>🔚 Conclusion</h2> <p>DBRL’s FY25 performance suggests a company in <strong>transition with upside potential</strong>, especially if:</p> <ul data-spread="false"> <li> <p>Tyre division stabilizes post labour unrest</p> </li> <li> <p>Proposed acquisitions materialize</p> </li> <li> <p>Global demand trends in steel and mobility remain strong</p> </li> </ul> <p>Investors in the <strong>unlisted space</strong> should track DBRL’s <strong>progress on regulatory clearances, revival of its tyre plant, and margin consistency</strong> before re-rating the company.</p> <div><hr /></div> <p>📌 <em>For any queries regarding DBRL’s unlisted shares or market valuation trends, connect with the UnlistedZone research desk.</em></p>
<p>India’s GIFT City is preparing for a game-changing moment — its first equity IPO under the newly approved IFSCA framework. According to Business Standard, multiple unlisted startups, including an ed-tech firm, are finalizing documents to raise USD 10–100 million directly through an IPO in GIFT City. If successful, this will mark the <strong>first time Indian unlisted companies can tap global investors in a foreign currency</strong> without listing on domestic exchanges like NSE or BSE. Let us understand with our popular QnA Format.</p> <div><hr /></div> <h2>🧾 Key Questions & Answers</h2> <div><hr /></div> <h3>1. What is the new ruling that allows unlisted Indian companies to raise funds via IPO in GIFT City?</h3> <p> In 2024, the <strong>International Financial Services Centres Authority (IFSCA)</strong> allowed unlisted Indian public companies to raise funds by directly listing on <strong>GIFT City-based international exchanges</strong> (like NSE IFSC or India INX). These IPOs are conducted in foreign currencies (usually USD) and do not require listing on NSE/BSE.</p> <div><hr /></div> <h3>2. Who can invest in these IPOs?</h3> <p> Eligible investors include:</p> <ul data-spread="false"> <li> <p><strong>NRIs</strong> (Non-Resident Indians)</p> </li> <li> <p><strong>Resident Indians</strong> (under RBI’s LRS route, up to USD 250,000/year)</p> </li> <li> <p><strong>Foreign Portfolio Investors (FPIs)</strong></p> </li> <li> <p><strong>Qualified Institutional Buyers (QIBs)</strong></p> </li> <li> <p><strong>Family Offices and Global HNIs</strong></p> </li> </ul> <p>Investors must open a <strong>GIFT City-compliant demat & trading account</strong> with a registered IFSC broker.</p> <div><hr /></div> <h3>3. Can normal retail or HNI investors from India invest in these IPOs?</h3> <p><strong>Yes</strong>, both <strong>retail and HNI investors</strong> from India can invest, but only through the <strong>Liberalised Remittance Scheme (LRS)</strong>, which allows up to <strong>USD 250,000 per year</strong> to be remitted abroad for investments. The process requires a <strong>foreign currency trading account</strong> and KYC through an IFSC-registered broker.</p> <div><hr /></div> <h3>4. How is listing via IPO in GIFT City different from raising funds through a foreign PE/VC investor?</h3> <p> </p> <table> <tbody> <tr> <th style="text-align: center;">GIFT City IPO</th> <th style="text-align: center;">Foreign PE/VC Investment</th> </tr> <tr> <td style="text-align: center;">Public fundraise via regulated IPO route</td> <td style="text-align: center;">Private capital from selective investors</td> </tr> <tr> <td style="text-align: center;">Transparent price discovery</td> <td style="text-align: center;">Negotiated valuations</td> </tr> <tr> <td style="text-align: center;">Retail & Institutional participation</td> <td style="text-align: center;">Only institutional participation</td> </tr> <tr> <td style="text-align: center;">Tradable shares post-listing</td> <td style="text-align: center;">Lock-in periods for PE/VCs</td> </tr> <tr> <td style="text-align: center;">Regulated by IFSCA</td> <td style="text-align: center;">Regulated via FEMA and SEBI (indirectly)</td> </tr> </tbody> </table> <div><hr /></div> <h3>5. What are the advantages for an unlisted company to do an IPO in GIFT City?</h3> <p> Key benefits include:</p> <ul data-spread="false"> <li> <p><strong>Access to global capital</strong> in USD</p> </li> <li> <p><strong>Lower compliance burden</strong> compared to SEBI’s mainboard</p> </li> <li> <p><strong>Faster listing window</strong> (as short as 1 day)</p> </li> <li> <p>Only <strong>10% minimum public float</strong> required (vs. 25% on NSE/BSE)</p> </li> <li> <p>Tax incentives for issuers and investors in the IFSC zone</p> </li> <li> <p>Builds <strong>valuation and brand</strong> ahead of potential domestic IPO</p> </li> </ul> <div><hr /></div> <h3>6. If a company lists in GIFT City, can it also trade on NSE/BSE in the future?</h3> <p> Not directly. Currently, GIFT City listings are <strong>independent of domestic exchanges</strong>. However, a company can later <strong>do a separate IPO in India</strong> and list on NSE/BSE, subject to SEBI approval.</p> <p>There is <strong>no automatic migration</strong>, but GIFT City listing can act as a <strong>pre-listing valuation benchmark</strong> for future India listings.</p> <div><hr /></div> <h3>7. If this model succeeds, will it impact PE/VC business in India?</h3> <p> Potentially, yes. If <strong>GIFT City listings scale up</strong>, companies may prefer <strong>market-based pricing and retail participation</strong> over traditional PE/VC rounds. This can lead to:</p> <ul data-spread="false"> <li> <p><strong>Increased valuation transparency</strong></p> </li> <li> <p>Faster <strong>liquidity options</strong> for founders</p> </li> <li> <p>Reduced dependency on PE-dominated term sheets</p> </li> <li> <p><strong>Disintermediation</strong> of early-stage capital (especially in mid-stage startups)</p> </li> </ul> <p>However, PE/VC firms will still play a critical role in pre-IPO funding and mentoring.</p> <div><hr /></div> <h2>Final Thoughts</h2> <p>The move to allow IPOs in GIFT City marks a <strong>paradigm shift</strong> for India’s startup and private equity ecosystem. For the first time, unlisted Indian companies can access <strong>global capital directly</strong> through an offshore IPO platform — potentially <strong>democratizing access</strong> and increasing market depth.</p> <p>The coming months will be crucial in determining whether this model becomes a scalable alternative to traditional IPOs and VC funding routes.</p>
<h3><strong>A) Company Overview: A Legacy of Trust and Growth</strong></h3> <p>Founded in 2000, <strong>HDFC Securities</strong> is a premier stockbroking and financial services firm in India and a key subsidiary of <strong>HDFC Bank</strong>, which owns a 94.55% stake. Over 25 years, the company has built a robust presence in equity broking, mutual fund distribution, and wealth management. HDFC Bank registered with both the <strong>NSE and BSE</strong> and is a top-5 broker by client base.</p> <div><hr /></div> <h3><strong>B) How HDFC Securities Earns Money</strong></h3> <p>HDFC Securities has a well-diversified revenue model:</p> <ul data-spread="false"> <li> <p><strong>Brokerage Income</strong>: Earned from trading in equity, derivatives, and currency segments. This remains the largest revenue contributor.</p> </li> <li> <p><strong>Distribution Fees</strong>: Commission from selling mutual funds, bonds, insurance, and other third-party products.</p> </li> <li> <p><strong>Margin Trade Facility (MTF)</strong>: Interest income from funds lent to clients for trading on margin.</p> </li> <li> <p><strong>Research & Advisory</strong>: Customised investment advisory through platforms like <strong>HSL Prime Research</strong> and <strong>HDFC Tru</strong>.</p> </li> <li> <p><strong>Wealth Management</strong>: Offering PMS, AIFs, debt advisory, and VC/PE access for HNIs and corporates.</p> </li> </ul> <div><hr /></div> <h3><strong>C) Financial Snapshot: FY22–FY25 Performance</strong></h3> <h4><strong>Key Financial Metrics</strong></h4> <table style="width: 60.0086%;"> <tbody> <tr> <th style="width: 37.9062%; text-align: center;">Metric</th> <th style="width: 15.5926%; text-align: center;">FY22</th> <th style="width: 15.5926%; text-align: center;">FY23</th> <th style="width: 15.5926%; text-align: center;">FY24</th> <th style="width: 15.5926%; text-align: center;">FY25</th> </tr> <tr> <td style="width: 37.9062%; text-align: center;">Revenue (Cr)</td> <td style="width: 15.5926%; text-align: center;">1,975</td> <td style="width: 15.5926%; text-align: center;">1,874</td> <td style="width: 15.5926%; text-align: center;">2,660</td> <td style="width: 15.5926%; text-align: center;">3,264</td> </tr> <tr> <td style="width: 37.9062%; text-align: center;">EBITDA (Cr)</td> <td style="width: 15.5926%; text-align: center;">1,504</td> <td style="width: 15.5926%; text-align: center;">1,377</td> <td style="width: 15.5926%; text-align: center;">1,936</td> <td style="width: 15.5926%; text-align: center;">2,351</td> </tr> <tr> <td style="width: 37.9062%; text-align: center;">EBITDA Margin (%)</td> <td style="width: 15.5926%; text-align: center;">74.03%</td> <td style="width: 15.5926%; text-align: center;">70.44%</td> <td style="width: 15.5926%; text-align: center;">70.38%</td> <td style="width: 15.5926%; text-align: center;">72.02%</td> </tr> <tr> <td style="width: 37.9062%; text-align: center;">PAT (Cr)</td> <td style="width: 15.5926%; text-align: center;">984</td> <td style="width: 15.5926%; text-align: center;">777</td> <td style="width: 15.5926%; text-align: center;">951</td> <td style="width: 15.5926%; text-align: center;">1,124</td> </tr> <tr> <td style="width: 37.9062%; text-align: center;">PAT Margin (%)</td> <td style="width: 15.5926%; text-align: center;">49.82%</td> <td style="width: 15.5926%; text-align: center;">41.45%</td> <td style="width: 15.5926%; text-align: center;">35.75%</td> <td style="width: 15.5926%; text-align: center;">34.44%</td> </tr> <tr> <td style="width: 37.9062%; text-align: center;">EPS </td> <td style="width: 15.5926%; text-align: center;">622.78</td> <td style="width: 15.5926%; text-align: center;">491.77</td> <td style="width: 15.5926%; text-align: center;">595.49</td> <td style="width: 15.5926%; text-align: center;">635.03</td> </tr> </tbody> </table> <h4> </h4> <h4><strong>Balance Sheet Snapshot (FY25)</strong></h4> <table> <tbody> <tr> <td style="text-align: center;">Assets</td> <td style="text-align: center;">Cr</td> <td style="text-align: center;">Liabilities</td> <td style="text-align: center;">Cr</td> </tr> <tr> <td style="text-align: center;">Fixed Assets</td> <td style="text-align: center;">161</td> <td style="text-align: center;">Share Capital</td> <td style="text-align: center;">17.7</td> </tr> <tr> <td style="text-align: center;">Investments</td> <td style="text-align: center;">1,064</td> <td style="text-align: center;">Reserves</td> <td style="text-align: center;">3,330</td> </tr> <tr> <td style="text-align: center;">Trade Receivables</td> <td style="text-align: center;">1,177</td> <td style="text-align: center;">Borrowings</td> <td style="text-align: center;">7,944</td> </tr> <tr> <td style="text-align: center;"><strong>Total Assets</strong></td> <td style="text-align: center;"><strong>14,031</strong></td> <td style="text-align: center;"><strong>Total Liabilities</strong></td> <td style="text-align: center;"><strong>14,031</strong></td> </tr> </tbody> </table> <h4> </h4> <h4><strong>Key Ratios</strong></h4> <ul data-spread="true"> <li> <p><strong>ROE</strong>: 33.58%</p> </li> <li> <p><strong>Debt-to-Equity</strong>: 2.37 (high leverage)</p> </li> <li> <p><strong>P/E</strong>: 17x (moderate valuation)</p> </li> <li> <p><strong>P/B</strong>: 5.69 (premium brand)</p> </li> </ul> <h4><strong>Cash Flow Trends</strong></h4> <p>Here are the key cash flow metrics from FY23 to FY25:</p> <table> <tbody> <tr> <td style="text-align: center;">Cash Flow Metric</td> <td style="text-align: center;">FY23 (₹ Cr)</td> <td style="text-align: center;">FY24 (₹ Cr)</td> <td style="text-align: center;">FY25 (₹ Cr)</td> </tr> <tr> <td style="text-align: center;">Cash from Operations</td> <td style="text-align: center;">371</td> <td style="text-align: center;">-2,747</td> <td style="text-align: center;">2,381</td> </tr> <tr> <td style="text-align: center;">Cash from Investment</td> <td style="text-align: center;">-973</td> <td style="text-align: center;">207</td> <td style="text-align: center;">-138</td> </tr> <tr> <td style="text-align: center;">Cash from Financing</td> <td style="text-align: center;">-294.6</td> <td style="text-align: center;">2,906</td> <td style="text-align: center;">-2,210</td> </tr> <tr> <td style="text-align: center;">Net Cash Generated</td> <td style="text-align: center;">-925</td> <td style="text-align: center;">406</td> <td style="text-align: center;">33</td> </tr> <tr> <td style="text-align: center;">Cash at Year-End</td> <td style="text-align: center;">393</td> <td style="text-align: center;">798</td> <td style="text-align: center;">831</td> </tr> </tbody> </table> <div><hr /></div> <h3><strong>D) HDFC Securities Stock Performance & Valuation</strong></h3> <h4><strong>Valuation Metrics (FY25)</strong></h4> <table> <tbody> <tr style="text-align: center;"> <td>Parameter</td> <td>Value</td> </tr> <tr style="text-align: center;"> <td>Price/Share</td> <td>₹10,750</td> </tr> <tr style="text-align: center;"> <td>Market Cap</td> <td>₹19,105 Cr</td> </tr> <tr style="text-align: center;"> <td>P/E Ratio</td> <td>17</td> </tr> <tr style="text-align: center;"> <td>P/B Ratio</td> <td>5.69</td> </tr> <tr style="text-align: center;"> <td>Debt to Equity</td> <td>2.37</td> </tr> <tr style="text-align: center;"> <td>ROE (%)</td> <td>33.58%</td> </tr> <tr> <td style="text-align: center;">Book Value/Share</td> <td style="text-align: center;">₹1,889.32</td> </tr> </tbody> </table> <h4> </h4> <h4><strong>Stock Price Trend</strong></h4> <ul data-spread="false"> <li> <p>All-time high near ₹19,000 in early 2022.</p> </li> <li> <p>Current price of ₹10,750 marks a <strong>28.33%</strong> drop from peak.</p> </li> <li> <p>Price remained largely stable around ₹12,000 during 2023–2024.</p> </li> <li> <p>Recent dip in 2025 hints at valuation correction amidst margin pressure.</p> </li> </ul> <p> <strong>Client Metrics (Fy 25)</strong></p> <ul data-spread="false"> <li> <p><strong>Customer Base</strong>: 6.8 million</p> </li> <li> <p><strong>Active Clients</strong>: 1.65 million</p> </li> <li> <p><strong>Equity Trade Volumes</strong>: +24% YoY</p> </li> <li> <p><strong>MTF Book Size</strong>: 95,520 Cr (71% YoY growth)</p> </li> <li> <p><strong>Mutual Fund AUM</strong>: Surpassed 25,000 Cr</p> </li> <li> <p><strong>Digital Brokerage Share</strong>: 85% in FY25 (vs 60% in FY24)</p> </li> </ul> <div><hr /></div> <h3><strong>E) HDFC Securities vs. Competitors (FY25)</strong></h3> <table> <tbody> <tr> <td style="text-align: center;">Companies</td> <td style="text-align: center;">Revenue (₹ Cr)</td> <td style="text-align: center;">EBITDA Margins</td> <td style="text-align: center;">PAT Margins</td> <td style="text-align: center;">D/E Ratio</td> <td style="text-align: center;">MCap (₹ Cr)</td> <td style="text-align: center;">P/E</td> </tr> <tr> <td style="text-align: center;">HDFC Securities</td> <td style="text-align: center;">3,264</td> <td style="text-align: center;">72.02%</td> <td style="text-align: center;">34.44%</td> <td style="text-align: center;">2.37</td> <td style="text-align: center;">19,105</td> <td style="text-align: center;">17.0</td> </tr> <tr> <td style="text-align: center;">Angel One</td> <td style="text-align: center;">5,239</td> <td style="text-align: center;">38.00%</td> <td style="text-align: center;">22.40%</td> <td style="text-align: center;">~0.69</td> <td style="text-align: center;">24,085</td> <td style="text-align: center;">20.5</td> </tr> <tr> <td style="text-align: center;">ICICI Securities</td> <td style="text-align: center;">6,332</td> <td style="text-align: center;">70.00%</td> <td style="text-align: center;">30.70%</td> <td style="text-align: center;">~3.89</td> <td style="text-align: center;">29,149</td> <td style="text-align: center;">15.2</td> </tr> </tbody> </table> <p> </p> <p>HDFC Securities stands out with the highest EBITDA and PAT margins, highlighting strong profitability. However, its high debt-to-equity ratio raises caution compared to its leaner peers. ICICI Securities leads in revenue and market cap, while Angel One shows strong growth with a balanced capital structure.</p> <h3> F) A Digital, Youth-Led Surge</h3> <h4><strong>Macroeconomic Backdrop</strong></h4> <ul data-spread="false"> <li> <p><strong>GDP Growth</strong>: 6.5% in FY24-25, 7.4% in Q4.</p> </li> <li> <p><strong>Inflation</strong>: 4.6% (lowest in 6 years)</p> </li> <li> <p><strong>Repo Rate</strong>: Cut from 6.5% to 5.5% in June 2025</p> </li> <li> <p><strong>FPIs</strong>: Net outflows of $14.6B in FY25</p> </li> </ul> <h4><strong>Investor Trends</strong></h4> <ul data-spread="false"> <li> <p><strong>Demat Accounts</strong>: 19 crore (vs 15.5 Cr in FY24)</p> </li> <li> <p><strong>New Investors in FY25</strong>: 7 crore (+27% YoY)</p> </li> <li> <p><strong>Tier II/III Penetration</strong>: 45% of new accounts</p> </li> <li> <p><strong>Median Investor Age</strong>: Dropped to 32 (from 38 in 2018)</p> </li> <li> <p><strong>Digital-Native Users</strong>: Growing dominance in equity markets</p> </li> </ul> <div><hr /></div> <h3><strong>G) Research, Innovation & Client-Centric Advisory</strong></h3> <ul data-spread="false"> <li> <p><strong>HSL Prime Research</strong>: New-age research arm using data-backed insights.</p> </li> <li> <p><strong>HDFC Tru</strong>: Transparent, commission-free advisory with 2 million+ clients.</p> </li> <li> <p><strong>Customized Offerings</strong>:</p> <ul data-spread="false"> <li> <p>Direct Equity, Bonds, Mutual Funds</p> </li> <li> <p>AIFs, PMS, NCDs</p> </li> <li> <p>Unlisted Securities, REITs, and more</p> </li> </ul> </li> </ul> <div><hr /></div> <h3>Final Verdict: Positioned for Sustainable Growth</h3> <p>HDFC Securities delivered a record-breaking FY25, marked by:</p> <ul data-spread="false"> <li> <p><strong>Revenue of 3,284 Cr and PAT of 1,124 Cr</strong></p> </li> <li> <p><strong>Strong ROE of 33.58%</strong></p> </li> <li> <p><strong>Customer-first tech adoption</strong></p> </li> </ul> <p>Despite margin pressures and high leverage, the company is riding a wave of digital transformation and demographic shifts. With a solid parentage in <strong>HDFC Bank</strong>, strong digital share, and expanding product suite, HDFC Securities is well-positioned to lead India's retail investing revolution.</p> <h3><strong>Disclaimer</strong>:</h3> <p>UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor.All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice.Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility.UnlistedZone does not guarantee any returns and shall not be held liable for any losses incurred as a result of investment decisions taken based on the information provided.</p>
<h2 data-pm-slice="1 1 []">Rights Issue Details & Fund Utilization</h2> <ul data-spread="false"> <li> <p><strong>Rights Issue Launched (May 27 – Jun 16, 2025)</strong>: Issued <strong>31 lakh equity shares at ₹325 each</strong> (face value ₹10 + premium ₹315), leading to a target raise of ₹100.75 cr.</p> </li> <li> <p><strong>Funds Raised So Far</strong>: ~₹85 cr successfully subscribed, with the remaining ₹15 cr expected by mid-July.</p> </li> <li> <p><strong>Investor Participation</strong>: Led by <strong>DS Group</strong> and existing backers like Kirin. Over <strong>300 investors</strong>, including a new <strong>family office</strong>, have participated.</p> </li> </ul> <p><strong>Purpose of Funds</strong>:</p> <ol start="1" data-spread="false"> <li> <p>Working capital & vendor payments</p> </li> <li> <p>General corporate expenses & compliance strengthening</p> </li> </ol> <div><hr /></div> <h2>🚨 Catalysts: What Triggered the Rights Issue</h2> <h3>1. Heavy Discount & Financial Pressure</h3> <ul data-spread="false"> <li> <p>Rights price (₹325) was <span data-sheets-root="1">55% lower than previous investment price (₹718</span>), signaling tight liquidity.</p> </li> <li> <p>FY24 metrics: Revenue fell 22% to ₹638.5 cr; losses surged 68% to ₹748.8 cr.</p> </li> </ul> <h3>2. Operational & Regulatory Disruption</h3> <ul data-spread="false"> <li> <p>Failure to timely renew licenses after shifting from “Private Ltd” → “Ltd” status led to a 4–6 month halt in several states, wiping out ₹80 cr in inventory.</p> </li> <li> <p>Supply chain and distribution suffered major downtime, causing sharp volume and revenue decline.</p> </li> </ul> <h3>3. Andhra Pradesh Facility Shutdown</h3> <ul data-spread="false"> <li> <p>Bira’s largest production facility in Andhra Pradesh, contributing 25–30% of its total output, was shut down in March 2025 due to non-payment of excise dues.</p> </li> <li> <p>The unit was fully vacated, and contracts terminated. Promoter personally intervened to retrieve stuck inventory.</p> </li> <li> <p>Post-closure, production dropped from 22 lakh cases/month to just 10,000–20,000 cases/month (via Mysuru contract unit only).</p> </li> </ul> <h3>4. Cost-Cutting & Realignment</h3> <ul data-spread="false"> <li> <p>Workforce halved from ~975 to ~500 employees.</p> </li> <li> <p>Shifted to an asset-light model using third-party contract manufacturers (Mysuru, Nagpur), while shutting units like Tripti Brewery (Madhya Pradesh).</p> </li> <li> <p>Manufacturing capacity cut by ~40%, projecting ₹600 cr in savings and improved margin outlook (targeting 66% gross margin by FY26).</p> </li> </ul> <div><hr /></div> <h2>🌱 Post-Issue Snapshot</h2> <ul data-spread="false"> <li> <p><strong>Operational Revival</strong>: Delhi & UP markets restarting; UP factory ramp-up planned by 2026.</p> </li> <li> <p><strong>Regulatory Remediation</strong>: Licenses re-registered across states; compliance infrastructure being strengthened.</p> </li> <li> <p><strong>Restructuring in Progress</strong>: Leaner cost structure, emphasis on contract brewing, and pivot to core high-demand markets (Delhi, Maharashtra, UP, Andhra).</p> </li> </ul> <div><hr /></div> <h2>What to Monitor Going Forward</h2> <table style="width: 51.3811%;"> <tbody> <tr> <th style="text-align: center; width: 30.4787%;">Focus Area</th> <th style="text-align: center; width: 69.443%;">Key Metrics</th> </tr> <tr> <td style="text-align: center; width: 30.4787%;"><strong>Rights Issue Closure</strong></td> <td style="text-align: center; width: 69.443%;">Achieving full ₹100 cr by mid-July</td> </tr> <tr> <td style="text-align: center; width: 30.4787%;"><strong>UP Brewery Setup</strong></td> <td style="text-align: center; width: 69.443%;">Construction and ramp-up over H2 FY25</td> </tr> <tr> <td style="text-align: center; width: 30.4787%;"><strong>Q4 FY25 Performance</strong></td> <td style="text-align: center; width: 69.443%;">Any sign of revenue recovery and EBITDA improvement</td> </tr> <tr> <td style="text-align: center; width: 30.4787%;"><strong>Additional Fundraising</strong></td> <td style="text-align: center; width: 69.443%;">Possibility of debt deals (e.g., ₹500 cr via BlackRock)</td> </tr> <tr> <td style="text-align: center; width: 30.4787%;"><strong>License Stability</strong></td> <td style="text-align: center; width: 69.443%;">No recurrence of compliance delays</td> </tr> </tbody> </table> <div><hr /></div> <h2> Summary Outlook</h2> <ul data-spread="false"> <li> <p>The rights issue is a <strong>strategic lifeline</strong> to stabilize operations and fund working capital post major disruptions.</p> </li> <li> <p>Bira is now more <strong>asset-light and focused</strong>, with strict cost controls and contract manufacturing.</p> </li> <li> <p>However, <strong>risks remain</strong>: completion of funding, UP facility delivery, no further regulatory setbacks, and early revenue recovery.</p> </li> <li> <p>For existing and prospective investors, the <strong>completion of rights issue & performance of H2 FY25</strong> will be critical catalysts for Bira’s unlisted market valuation.</p> </li> </ul>
<h3>A) Introduction: </h3> <p><strong>Arteria Secures ₹100 Cr to Scale Up</strong> Bengaluru-based <strong>Arteria Technologies</strong>, a rising star in the Indian SaaS ecosystem, has successfully raised <strong>₹100 crore in Series B funding</strong>, led by <strong>ICICI Venture</strong>. This funding round reflects the growing investor confidence in <strong>AI-driven supply chain and embedded finance solutions</strong>. The startup plans to use the capital to boost product innovation, expand geographically, and strengthen its workforce.</p> <p><br /><strong>B) What Does Arteria Technologies Do?</strong></p> <p>Arteria Technologies offers a robust <strong>Supply Chain SaaS platform</strong> designed to bring visibility, automation, and financial flexibility to enterprises. Their product suite includes:</p> <ul data-spread="false"> <li> <p><strong>Upstream and Downstream Supply Chain Management</strong></p> </li> <li> <p><strong>Real-Time Visibility & Predictive Analytics</strong></p> </li> <li> <p><strong>Embedded Financing Solutions</strong> to improve working capital efficiency for suppliers and distributors</p> </li> </ul> <p>The platform currently serves <strong>100+ enterprise clients</strong> across <strong>FMCG, automotive, and manufacturing sectors</strong>.</p> <p><br /><strong>C) Business Model: How Arteria Earns Money?</strong></p> <p>Arteria Technologies follows a B2B SaaS model, offering its platform on a <strong>subscription and usage-based pricing</strong>. Revenue is generated through:</p> <ul data-spread="false"> <li> <p>Tiered pricing based on enterprise scale and modules used</p> </li> <li> <p>Commission on embedded financing deals facilitated through its platform</p> </li> <li> <p>Custom analytics and integration solutions for large enterprises</p> </li> </ul> <p><strong>D) Funding Purpose: Where Will ₹100 Cr Be Used?</strong> <br />The raised capital will help Arteria in multiple strategic areas:</p> <ol start="1" data-spread="true"> <li> <p><strong>AI & Product Development:</strong></p> <ul data-spread="false"> <li> <p>Develop next-gen <strong>AI tools</strong> for predictive supply chain analytics</p> </li> <li> <p>Improve automation and real-time data visibility features</p> </li> </ul> </li> <li> <p><strong>Market Expansion:</strong></p> <ul data-spread="false"> <li> <p>Deepen penetration in India</p> </li> <li> <p>Expand to <strong>Southeast Asia and the Middle East</strong></p> </li> </ul> </li> <li> <p><strong>Talent Acquisition:</strong></p> <ul data-spread="false"> <li> <p>Hire <strong>top AI/ML engineers and supply chain specialists</strong></p> </li> </ul> </li> <li> <p><strong>New Product Launches:</strong></p> <ul data-spread="false"> <li> <p>Focus on <strong>financing products for SMEs</strong> to ease their working capital woes</p> </li> </ul> </li> </ol> <p><strong>E) Why Investors Are Bullish on Arteria</strong> <strong>ICICI Venture's investment</strong> <br />in Arteria reflects broader market trends:</p> <ul data-spread="false"> <li> <p>Growing adoption of <strong>digital supply chain tools</strong> post-COVID</p> </li> <li> <p>Rising demand for <strong>AI-led logistics and predictive analytics</strong></p> </li> <li> <p>Emergence of <strong>embedded finance</strong> as a core value addition in B2B platforms</p> </li> </ul> <p>India's supply chain tech market is expected to <strong>cross $50 billion</strong>, and Arteria is well-positioned to capture significant market share.</p> <p><strong>F) Growth Triggers & Future Roadmap</strong></p> <ul data-spread="false"> <li> <p>Expansion in untapped emerging markets</p> </li> <li> <p>Launch of tailored financing products for mid-size businesses</p> </li> <li> <p>Strong tech roadmap with focus on AI-first capabilities</p> </li> <li> <p>Increase in recurring revenue through long-term SaaS contracts</p> </li> </ul> <p><strong>G) Risk Factors to Watch</strong></p> <ul data-spread="false"> <li> <p>High competition from global SaaS players</p> </li> <li> <p>Regulatory hurdles in embedded finance domain</p> </li> <li> <p>Scalability challenges in diverse geographies</p> </li> </ul> <p><strong>H) Conclusion: </strong></p> <p><strong>Arteria’s Vision for the Future</strong> Arteria Technologies is on a mission to <strong>revolutionize how supply chains operate</strong> through the use of <strong>AI, automation, and finance integration</strong>. Backed by ICICI Venture and armed with fresh capital, the company is all set to disrupt logistics, inventory management, and enterprise financing in India and beyond.</p> <div><hr /></div> <p><strong>Disclaimer:</strong> <em>UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor. All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice. Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility.</em></p>
<p>Once known primarily as a reliable infrastructure provider for India’s telecom sector, <strong>Pace Digitek</strong> is undergoing a <strong>massive transformation</strong>. From laying OFC cables and setting up telecom towers across regions, the company is now gearing up for the <strong>next big leap</strong>—<strong>Battery Energy Storage Systems (BESS)</strong> manufacturing.</p> <p>At the heart of this transformation lies its key subsidiary, <strong>Lineage Powertech Pvt Ltd</strong>, and a new <strong>5 GWh capacity manufacturing facility in Bidadi, Bengaluru</strong>.</p> <div><hr /></div> <h2>A) <strong>The Beginning: A Telecom Backbone Builder</strong></h2> <p>Pace Digitek’s legacy lies in building the invisible backbone of India’s digital economy. From <strong>installation of telecom towers</strong>, <strong>fiber optic cable networks</strong>, to <strong>managed services</strong>, the company has been a silent enabler of India’s 4G and now 5G rollout.</p> <p>But as the <strong>telecom infrastructure sector matures</strong> and growth slows, the company took a bold call—<strong>diversify into green energy</strong>.</p> <div><hr /></div> <h2>B) <strong>The Turning Point: Acquisition of Lineage Powertech</strong></h2> <p>Recognizing the opportunities in clean energy and power storage, Pace Digitek acquired <strong>Lineage Powertech</strong>, a technology firm with focus on energy systems. This acquisition paved the way for entering the <strong>Battery Energy Storage Systems (BESS)</strong> segment—a high-growth sector expected to expand at <strong>25–30% CAGR</strong> globally.</p> <div><hr /></div> <h2>C) <strong>5 GWh BESS Manufacturing Facility – A Game Changer</strong></h2> <p>In April 2025, <strong>Lineage commissioned its 5 GWh BESS manufacturing plant in Bidadi, Karnataka</strong>.</p> <p>This facility is designed to produce:</p> <table style="width: 101.026%;"> <tbody> <tr> <th style="text-align: center; width: 29.8547%;">Component</th> <th style="text-align: center; width: 34.3895%;">Type</th> <th style="text-align: center; width: 35.6492%;">In-house / Outsourced</th> </tr> <tr> <td style="text-align: center; width: 29.8547%;"><strong>Battery Packs</strong></td> <td style="text-align: center; width: 34.3895%;">LFP and NMC chemistries</td> <td style="text-align: center; width: 35.6492%;">✅ In-house</td> </tr> <tr> <td style="text-align: center; width: 29.8547%;"><strong>Battery Management Systems</strong></td> <td style="text-align: center; width: 34.3895%;">Monitoring, protection, communication</td> <td style="text-align: center; width: 35.6492%;">✅ Integration In-house; sourcing chips</td> </tr> <tr> <td style="text-align: center; width: 29.8547%;"><strong>Containerized BESS Units</strong></td> <td style="text-align: center; width: 34.3895%;">50kWh to 1MWh scalable systems</td> <td style="text-align: center; width: 35.6492%;">✅ In-house design</td> </tr> <tr> <td style="text-align: center; width: 29.8547%;"><strong>Thermal Management Systems</strong></td> <td style="text-align: center; width: 34.3895%;">Cooling, ventilation</td> <td style="text-align: center; width: 35.6492%;">✅ Integrated with external parts</td> </tr> <tr> <td style="text-align: center; width: 29.8547%;"><strong>Battery Cells</strong></td> <td style="text-align: center; width: 34.3895%;">Lithium-ion based</td> <td style="text-align: center; width: 35.6492%;">❌ Sourced from China/Korea/India</td> </tr> <tr> <td style="text-align: center; width: 29.8547%;"><strong>Software / EMS</strong></td> <td style="text-align: center; width: 34.3895%;">Energy management software</td> <td style="text-align: center; width: 35.6492%;">✅ Partially in-house; partially licensed</td> </tr> <tr> <td style="text-align: center; width: 29.8547%;"><strong>Testing & Certification</strong></td> <td style="text-align: center; width: 34.3895%;">Safety, thermal, endurance</td> <td style="text-align: center; width: 35.6492%;">✅ In-house + external NABL labs</td> </tr> </tbody> </table> <p>The goal is to <strong>own the entire value chain from pack assembly to system integration</strong>, while gradually reducing dependence on foreign cells and control software.</p> <div><hr /></div> <h2>D) <strong>How BESS Can Transform Pace Digitek</strong></h2> <ul data-spread="false"> <li> <p><strong>Higher Margin Business</strong>: BESS projects command better pricing and margins.</p> </li> <li> <p><strong>New Market Verticals</strong>: Energy, EV infra, commercial & industrial clients, data centers, DISCOMs.</p> </li> <li> <p><strong>Tender Participation</strong>: Rising interest in grid-scale BESS tenders (SECI, NTPC, etc.).</p> </li> <li> <p><strong>Brand Transition</strong>: From infra service vendor to a <strong>cleantech OEM</strong>.</p> </li> <li> <p><strong>Cross-Sell Potential</strong>: Telecom clients like Jio, Airtel, BSNL may become BESS clients.</p> <h2><strong>What is BESS and Why It Matters?</strong></h2> <p><strong>Battery Energy Storage Systems (BESS)</strong> are industrial-grade batteries that store energy and discharge when needed—essential for modern renewable-powered grids.</p> <h3>🌍 <strong>Key Applications:</strong></h3> <ul data-spread="false"> <li> <p>Renewable energy storage</p> </li> <li> <p>Grid balancing</p> </li> <li> <p>Mission-critical backup</p> </li> <li> <p>EV charging infra</p> </li> <li> <p>Industrial energy efficiency</p> </li> </ul> </li> </ul> <div><hr /></div> <h2>E) <strong>Business Model & Revenue Streams of Pace Digitek</strong></h2> <h3><strong>1. Business Model: Integrated Infrastructure Solutions</strong></h3> <p>Pace Digitek operates as a full-service provider in telecom and energy infrastructure, offering:</p> <p><strong>Core Services:</strong></p> <ul data-spread="false"> <li> <p><strong>Power Management Systems</strong>: For telecom towers.</p> </li> <li> <p><strong>Optic Fiber Laying</strong>: High-speed fiber networks.</p> </li> <li> <p><strong>Renewable Energy Solutions</strong>: Green energy project implementation.</p> </li> </ul> <p><strong>Market Segments Served:</strong></p> <ul data-spread="false"> <li> <p>Telecom Operators</p> </li> <li> <p>Government Electrification Projects</p> </li> <li> <p>Private Infra Developers</p> </li> </ul> <h3><strong>2. Revenue Model: Diversified Income Streams</strong></h3> <table style="width: 50.2628%;"> <tbody> <tr> <td style="text-align: center; width: 29.052%;">Revenue Source</td> <td style="text-align: center; width: 70.988%;">Description</td> </tr> <tr> <td style="text-align: center; width: 29.052%;">Product Sales</td> <td style="text-align: center; width: 70.988%;">Power & renewable energy products</td> </tr> <tr> <td style="text-align: center; width: 29.052%;">Project Implementation</td> <td style="text-align: center; width: 70.988%;">OFC & infra-based project income</td> </tr> <tr> <td style="text-align: center; width: 29.052%;">O&M Services</td> <td style="text-align: center; width: 70.988%;">Recurring income from long-term maintenance contracts</td> </tr> </tbody> </table> <div><hr /></div> <h2>F) Financial Summary Snapshot Of Pace Digitek (2022–2024)</h2> <table style="width: 50.3879%; height: 167.154px;"> <tbody> <tr style="height: 18.4615px;"> <td style="width: 22.4728%; text-align: center; height: 18.4615px;">Metric</td> <td style="width: 25.6141%; text-align: center; height: 18.4615px;">2023</td> <td style="width: 24.6476%; text-align: center; height: 18.4615px;">2024</td> <td style="width: 27.3056%; text-align: center; height: 18.4615px;">6M FY25</td> </tr> <tr style="height: 18.4615px;"> <td style="width: 22.4728%; text-align: center; height: 18.4615px;"><strong>Revenue (₹ Cr)</strong></td> <td style="width: 25.6141%; text-align: center; height: 18.4615px;">503.19</td> <td style="width: 24.6476%; text-align: center; height: 18.4615px;">2434.4</td> <td style="width: 27.3056%; text-align: center; height: 18.4615px;">1188.3</td> </tr> <tr style="height: 18.4615px;"> <td style="width: 22.4728%; text-align: center; height: 18.4615px;"><strong>PAT (₹ Cr)</strong></td> <td style="width: 25.6141%; text-align: center; height: 18.4615px;">16.15</td> <td style="width: 24.6476%; text-align: center; height: 18.4615px;">229</td> <td style="width: 27.3056%; text-align: center; height: 18.4615px;">152</td> </tr> <tr style="height: 19.4615px;"> <td style="width: 22.4728%; text-align: center; height: 19.4615px;"><strong>EBITDA (₹ Cr)</strong></td> <td style="width: 25.6141%; text-align: center; height: 19.4615px;">39.7</td> <td style="width: 24.6476%; text-align: center; height: 19.4615px;">423</td> <td style="width: 27.3056%; text-align: center; height: 19.4615px;">300</td> </tr> <tr style="height: 36.9231px;"> <td style="width: 22.4728%; text-align: center; height: 36.9231px;"><strong>Net Profit Margin (%)</strong></td> <td style="width: 25.6141%; text-align: center; height: 36.9231px;">3.29%</td> <td style="width: 24.6476%; text-align: center; height: 36.9231px;">9.44%</td> <td style="width: 27.3056%; text-align: center; height: 36.9231px;">12.79%</td> </tr> <tr style="height: 36.9231px;"> <td style="width: 22.4728%; text-align: center; height: 36.9231px;"><strong>Cash from Operations (₹ Cr)</strong></td> <td style="width: 25.6141%; text-align: center; height: 36.9231px;">-43.7</td> <td style="width: 24.6476%; text-align: center; height: 36.9231px;">213.9</td> <td style="width: 27.3056%; text-align: center; height: 36.9231px;">-530.8</td> </tr> <tr style="height: 18.4615px;"> <td style="width: 22.4728%; text-align: center; height: 18.4615px;"><strong>Closing Cash (₹ Cr)</strong></td> <td style="width: 25.6141%; text-align: center; height: 18.4615px;">-51.3</td> <td style="width: 24.6476%; text-align: center; height: 18.4615px;">8.54</td> <td style="width: 27.3056%; text-align: center; height: 18.4615px;">132.7</td> </tr> </tbody> </table> <div><hr /></div> <h2>G) <strong>Unlisted Market Price Movement</strong></h2> <h3>Price Journey Summary:</h3> <ul data-spread="false"> <li> <p><strong>Jan 2025</strong>: Price stable around ₹240–₹245.</p> </li> <li> <p><strong>Feb 2025</strong>: Major spike to <strong>₹300+</strong> following news of the <strong>BESS facility announcement</strong>.</p> </li> <li> <p><strong>Late Feb – Early Mar</strong>: Sharp correction to <strong>₹240</strong> due to profit booking.</p> </li> <li> <p><strong>March 2025</strong>: Sudden drop to <strong>₹210</strong>—possibly triggered by muted financials for FY24.</p> </li> <li> <p><strong>April 2025</strong>: Short rally to ₹250+, followed by gradual decline.</p> </li> <li> <p><strong>May to June 2025</strong>: Rangebound between <strong>₹210–₹215</strong>, showing low investor activity.</p> </li> <li> <p><strong>July 9, 2025</strong>: Current Price: <strong>₹205</strong> — down <strong>15.17%</strong> in a single session.</p> </li> </ul> <h3>Key Observations:</h3> <ul data-spread="false"> <li> <p>The stock shows <strong>high volatility</strong>, often reacting to company announcements.</p> </li> <li> <p>Sustained value will depend on <strong>execution of BESS strategy</strong> and market sentiment in the unlisted space.</p> </li> </ul> <div><hr /></div> <h2>H) <strong>Valuation & Peer Comparison Snapshot</strong></h2> <table> <tbody> <tr> <td style="text-align: center;">Companies</td> <td style="text-align: center;">Revenue (in ₹ Cr)</td> <td style="text-align: center;">EBITDA Margins</td> <td style="text-align: center;">PAT Margins</td> <td style="text-align: center;">ROCE</td> <td style="text-align: center;">D/E Ratio</td> <td style="text-align: center;">MCap (in ₹ Cr)</td> <td style="text-align: center;">P/E</td> </tr> <tr> <td style="text-align: center;">Pace Digitek Limited(6M FY25)</td> <td style="text-align: center;">1188.3</td> <td style="text-align: center;">25.25%</td> <td style="text-align: center;">12.79%</td> <td style="text-align: center;">18.72%</td> <td style="text-align: center;">0.49</td> <td style="text-align: center;">3658</td> <td style="text-align: center;">15.08</td> </tr> <tr> <td style="text-align: center;">HFCL Limited(FY 25)</td> <td style="text-align: center;">4065</td> <td style="text-align: center;">11.00%</td> <td style="text-align: center;">4.26%</td> <td style="text-align: center;">7.67%</td> <td style="text-align: center;">0.33</td> <td style="text-align: center;">11,902</td> <td style="text-align: center;">98.67</td> </tr> <tr> <td style="text-align: center;">Exicom Tele-Systems Limited(FY25)</td> <td style="text-align: center;">868</td> <td style="text-align: center;">-4%</td> <td style="text-align: center;">-12.70%</td> <td style="text-align: center;">-5.94%</td> <td style="text-align: center;">1.15</td> <td style="text-align: center;">2567</td> <td style="text-align: center;">In loss</td> </tr> <tr> <td style="text-align: center;">Bondada Engineering Limited(FY25)</td> <td style="text-align: center;">1571</td> <td style="text-align: center;">11%</td> <td style="text-align: center;">7.34%</td> <td style="text-align: center;">40.40%</td> <td style="text-align: center;">0.41</td> <td style="text-align: center;">4731</td> <td style="text-align: center;">42.3</td> </tr> </tbody> </table> <div><hr /></div> <h2>I) <strong>Risk Factors & Mitigation Strategies</strong></h2> <table style="width: 100.901%;"> <tbody> <tr> <td style="text-align: center; width: 27.2896%;">Risk Factor</td> <td style="text-align: center; width: 29.9184%;">Impact Area</td> <td style="text-align: center; width: 42.6869%;">Mitigation Need</td> </tr> <tr> <td style="text-align: center; width: 27.2896%;">Customer Concentration (83–99%)</td> <td style="text-align: center; width: 29.9184%;">Revenue collapse if 1–2 key clients exit</td> <td style="text-align: center; width: 42.6869%;">Diversify client base; strengthen contract terms</td> </tr> <tr> <td style="text-align: center; width: 27.2896%;">Govt. Tender Dependence (95%)</td> <td style="text-align: center; width: 29.9184%;">Margin pressure; policy risk</td> <td style="text-align: center; width: 42.6869%;">Improve cost efficiency; explore private sector opportunities</td> </tr> <tr> <td style="text-align: center; width: 27.2896%;">Telecom Sector Over-reliance (94%)</td> <td style="text-align: center; width: 29.9184%;">Vulnerable to telecom capex cycles</td> <td style="text-align: center; width: 42.6869%;">Expand energy/ICT verticals; reduce sector dependence</td> </tr> <tr> <td style="text-align: center; width: 27.2896%;">Geographic Concentration (70%)</td> <td style="text-align: center; width: 29.9184%;">Regional risks (political/natural)</td> <td style="text-align: center; width: 42.6869%;">Expand geographically; decentralize operations</td> </tr> <tr> <td style="text-align: center; width: 27.2896%;">Vendor Dependency (62%)</td> <td style="text-align: center; width: 29.9184%;">Supply chain disruption</td> <td style="text-align: center; width: 42.6869%;">Multi-sourcing strategy; vendor redundancy</td> </tr> </tbody> </table> <div><hr /></div> <h2>J) <strong>UnlistedZone View: Strong Execution = Multi-Year Growth</strong></h2> <p>This is a <strong>make-or-break moment</strong> for Pace Digitek. With growing demand, a live facility, and integrated manufacturing capabilities, the company is well-positioned to become a <strong>pioneer in India’s energy storage market</strong>.</p> <div><hr /></div> <h2><strong>🔍 Conclusion</strong></h2> <p>From a telecom infra contractor to a cleantech manufacturing challenger, <strong>Pace Digitek Infra's journey is bold and calculated</strong>. With strong financials, a future-focused roadmap, and a high-potential BESS strategy, the company is one to watch in India’s evolving infrastructure landscape.</p> <div><hr /></div> <p><strong>Disclaimer:</strong> UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor. All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice. Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility.</p> <div><hr /></div>
<h2>A) About the Company</h2> <p><strong>Parry Agro Industries Ltd.</strong>, a Murugappa Group company, is one of India's top producers and exporters of premium orthodox, organic, and CTC teas. Headquartered in Coimbatore, the company owns and operates over <strong>3,200 hectares of tea estates</strong> across Tamil Nadu, Kerala, and Assam.</p> <p>With a strong focus on <strong>sustainability and export-grade quality</strong>, Parry Agro is a trusted supplier of <strong>bulk and specialty teas</strong> to both Indian and global markets — including Europe, North America, and the Middle East.</p> <h2>B) Business Model: How Parry Agro Makes Money</h2> <p>Parry Agro earns revenue primarily from the <strong>cultivation, processing, and export of tea</strong>, with an emphasis on:</p> <ul data-spread="false"> <li> <p><strong>Orthodox, Organic, and CTC Teas</strong>: High-grade and specialty teas grown in high-yield estates.</p> </li> <li> <p><strong>Export Revenue</strong>: A significant share of income is from international markets, offering better pricing and foreign exchange benefits.</p> </li> <li> <p><strong>Sustainable Certifications</strong>: Rainforest Alliance and Trustea certifications help attract ESG-aligned buyers.</p> </li> <li> <p><strong>Diversified Product Streams</strong>: The company reported ₹239.48 Cr revenue from product sales in FY25, which includes:</p> <ul data-spread="false"> <li> <p><strong>Tea</strong>: ₹237.27 Cr (vs. ₹223.83 Cr in FY24)</p> </li> <li> <p><strong>Pepper</strong>: ₹2.20 Cr (vs. ₹1.53 Cr in FY24)</p> </li> </ul> </li> <li> <p><strong>Other Operating Revenue</strong> (₹6.87 Cr in FY25 vs. ₹8.02 Cr in FY24):</p> <ul data-spread="false"> <li> <p>Sale of Tea Waste: ₹2.81 Cr</p> </li> <li> <p>Timber: ₹2.15 Cr</p> </li> <li> <p>Scrap: ₹0.41 Cr</p> </li> <li> <p>Subsidies: ₹0.16 Cr</p> </li> <li> <p>Income from Eco Ops: ₹0.34 Cr</p> </li> <li> <p>Export Benefits: ₹1.00 Cr</p> </li> </ul> </li> <li> <p><strong>Services Income</strong>: ₹2.89 Cr (almost flat YoY)</p> </li> </ul> <p>The company benefits from price premiums due to its <strong>sustainability practices and estate legacy</strong> within the Murugappa Group.</p> <h2>C) Products Offered</h2> <h3>Organic & Orthodox Teas</h3> <p>Parry Agro is a pioneer in organic cultivation using eco-sustainable methods, strict buffer zones, and no synthetic fertilizers. These teas are <strong>NOP and NPOP certified</strong> for export, especially to the US and EU.</p> <h3>Conventional Tea Cultivation</h3> <p>In addition to organic farming, Parry Agro also operates conventional tea estates under <strong>Trustea-compliant models</strong>, ensuring economic, agronomic, and environmental sustainability.</p> <h2>D) Financial Health Snapshot – FY 2025 vs. FY 2024</h2> <h3>1. Balance Sheet Highlights (₹ in Cr)</h3> <table> <tbody> <tr> <th style="text-align: center;">Key Metric</th> <th style="text-align: center;">FY25 (₹ Cr)</th> <th style="text-align: center;">FY24 (₹ Cr)</th> <th style="text-align: center;">Change</th> </tr> <tr> <td style="text-align: center;">Total Assets</td> <td style="text-align: center;">116.93</td> <td style="text-align: center;">113.88</td> <td style="text-align: center;">↑ 2.7%</td> </tr> <tr> <td style="text-align: center;">Fixed Assets</td> <td style="text-align: center;">60.02</td> <td style="text-align: center;">59.32</td> <td style="text-align: center;">↑ 1.2%</td> </tr> <tr> <td style="text-align: center;">Inventories</td> <td style="text-align: center;">32.72</td> <td style="text-align: center;">30.89</td> <td style="text-align: center;">↑ 5.9%</td> </tr> <tr> <td style="text-align: center;">Total Current Liability</td> <td style="text-align: center;">42.13</td> <td style="text-align: center;">41.92</td> <td style="text-align: center;">↑ 0.5%</td> </tr> <tr> <td style="text-align: center;">Debt</td> <td style="text-align: center;">1.95</td> <td style="text-align: center;">2.12</td> <td style="text-align: center;">↓ 8.0%</td> </tr> <tr> <td style="text-align: center;">Total Equity</td> <td style="text-align: center;">68.54</td> <td style="text-align: center;">66.14</td> <td style="text-align: center;">↑ 3.6%</td> </tr> </tbody> </table> <h3>2. P&L Summary (₹ in Cr)</h3> <table> <tbody> <tr> <td style="text-align: center;">Metric</td> <td style="text-align: center;">FY25</td> <td style="text-align: center;">FY24</td> <td style="text-align: center;">Change</td> </tr> <tr> <td style="text-align: center;">Revenue from Operations</td> <td style="text-align: center;">246.35</td> <td style="text-align: center;">233.87</td> <td style="text-align: center;">↑ 5.3%</td> </tr> <tr> <td style="text-align: center;">Total Income</td> <td style="text-align: center;">248.44</td> <td style="text-align: center;">239.67</td> <td style="text-align: center;">↑ 3.7%</td> </tr> <tr> <td style="text-align: center;">Total Expenses</td> <td style="text-align: center;">250.35</td> <td style="text-align: center;">248.28</td> <td style="text-align: center;">↑ 0.8%</td> </tr> <tr> <td style="text-align: center;">Net Profit</td> <td style="text-align: center;">2.39</td> <td style="text-align: center;">-2.97</td> <td style="text-align: center;">Turnaround</td> </tr> <tr> <td style="text-align: center;">EBITDA</td> <td style="text-align: center;">-4.49</td> <td style="text-align: center;">-5.62</td> <td style="text-align: center;">↑ 20.3%</td> </tr> <tr> <td style="text-align: center;">EBITDA Margin</td> <td style="text-align: center;">-1.8%</td> <td style="text-align: center;">-2.4%</td> <td style="text-align: center;">+0.6pp</td> </tr> <tr> <td style="text-align: center;">Net Profit Margin</td> <td style="text-align: center;">1.0%</td> <td style="text-align: center;">-1.3%</td> <td style="text-align: center;">+2.3pp</td> </tr> <tr> <td style="text-align: center;">EPS (Basic)</td> <td style="text-align: center;">-7.24</td> <td style="text-align: center;">-24.30</td> <td style="text-align: center;">↑ 70.2%</td> </tr> </tbody> </table> <h3>3. Cash Flow Analysis (₹ in Cr)</h3> <table> <tbody> <tr> <td style="text-align: center;">Activity</td> <td style="text-align: center;">FY25 (₹ Cr)</td> <td style="text-align: center;">FY24 (₹ Cr)</td> <td style="text-align: center;">Comment</td> </tr> <tr> <td style="text-align: center;">Operating Cash Flow</td> <td style="text-align: center;">+2.39</td> <td style="text-align: center;">-6.85</td> <td style="text-align: center;">Turned positive</td> </tr> <tr> <td style="text-align: center;">Investing Cash Flow</td> <td style="text-align: center;">-1.95</td> <td style="text-align: center;">+8.17</td> <td style="text-align: center;">Capex-led outflow</td> </tr> <tr> <td style="text-align: center;">Net Change in Cash</td> <td style="text-align: center;">+0.40</td> <td style="text-align: center;">-0.40</td> <td style="text-align: center;">Positive swing</td> </tr> </tbody> </table> <h2>E) Valuation Analysis</h2> <table style="width: 18.5047%;"> <tbody> <tr> <td style="width: 47.471%; text-align: center;">Parameter</td> <td style="width: 52.6184%; text-align: center;">Value</td> </tr> <tr> <td style="width: 47.471%; text-align: center;">Price per Share</td> <td style="width: 52.6184%; text-align: center;">₹1,740</td> </tr> <tr> <td style="width: 47.471%; text-align: center;">Book Value</td> <td style="width: 52.6184%; text-align: center;">₹209.62</td> </tr> <tr> <td style="width: 47.471%; text-align: center;">P/B Ratio</td> <td style="width: 52.6184%; text-align: center;">8.3x</td> </tr> <tr> <td style="width: 47.471%; text-align: center;">P/E Ratio</td> <td style="width: 52.6184%; text-align: center;">273.8x</td> </tr> <tr> <td style="width: 47.471%; text-align: center;">ROE</td> <td style="width: 52.6184%; text-align: center;">3.49%</td> </tr> <tr> <td style="width: 47.471%; text-align: center;">Market Cap</td> <td style="width: 52.6184%; text-align: center;">₹654 Cr</td> </tr> <tr> <td style="width: 47.471%; text-align: center;">Debt-to-Equity</td> <td style="width: 52.6184%; text-align: center;">0.03</td> </tr> </tbody> </table> <ul data-spread="false"> <li> <p><strong>P/E Ratio</strong>: Market Cap ₹654 Cr ÷ Net Profit ₹2.39 Cr = <strong>273.8x</strong> — implies very high premium pricing.</p> </li> <li> <p><strong>ROE</strong>: Net Profit ₹2.39 Cr ÷ Equity ₹68.54 Cr = <strong>3.49%</strong> — remains on the lower side.</p> </li> <li> <p><strong>Debt-to-Equity</strong>: ₹1.95 Cr ÷ ₹68.54 Cr = <strong>0.03</strong> — indicates almost debt-free status.</p> </li> </ul> <p>The stock appears <strong>overvalued based on earnings</strong>, but scarcity, group brand, and ESG factors may justify the steep valuation.</p> <h2>F) Investment Rationale</h2> <ul data-spread="false"> <li> <p><strong>Group Backing</strong>: Stable governance as part of the Murugappa Group.</p> </li> <li> <p><strong>Premium Estate Portfolio</strong>: High-yield gardens in regions like Assam, Kerala, and Nilgiris.</p> </li> <li> <p><strong>Export Orientation</strong>: Diversified global markets help de-risk from domestic cycles.</p> </li> <li> <p><strong>Sustainability Advantage</strong>: Certifications boost ESG investment appeal.</p> </li> <li> <p><strong>Favorable Demand Trends</strong>: Rising consumption of premium and organic teas globally.</p> </li> </ul> <h2>Conclusion: On the Road to Recovery?</h2> <p>Despite still being in the red, <strong>Parry Agro Industries Ltd. has demonstrated solid financial improvements in FY25</strong>, including:</p> <ul data-spread="false"> <li> <p>Returned to net profit from prior year losses</p> </li> <li> <p>EBITDA margin improved significantly</p> </li> <li> <p>Operating cash flow turned positive</p> </li> </ul> <p>The business is stabilizing its financials while investing in growth. With a strong brand legacy, sustainable cultivation practices, and improving efficiency, <strong>Parry Agro appears poised for a potential turnaround</strong>, provided macro conditions remain favorable.</p> <h2>Disclaimer:</h2> <p>UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor. All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice. Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility. UnlistedZone does not guarantee any returns and shall not be held liable for any losses incurred as a result of investment decisions taken based on the information provided.</p> <p> </p>
<h3><strong>A) Why Are Agri-Derivatives Losing Momentum Despite Government Push?</strong></h3> <p>Over the past few years, agri-commodity derivatives trading has seen a persistent decline—even as the government has launched multiple initiatives to link farmers with formal marketplaces. What went wrong?</p> <ul data-spread="false"> <li> <p><strong>Frequent trading bans</strong> on key agri-commodities</p> </li> <li> <p><strong>Unfavorable policy environment</strong> for commodity traders</p> </li> <li> <p><strong>Low participation</strong> from FPOs and retail traders</p> </li> </ul> <p>This ongoing downtrend has directly affected <strong>NCDEX (National Commodity & Derivatives Exchange)</strong>, India’s premier agri-commodity exchange. Once a robust platform for hedging and price discovery, NCDEX has suffered due to plummeting volumes. For those tracking <strong>NCDEX unlisted shares</strong>, this slump could either signal concern—or a timely entry point if reforms succeed.</p> <h3><strong>B) What is SEBI Doing to Revive the Segment?</strong></h3> <p>To tackle this market fatigue, SEBI is gearing up with a structured strategy. Two dedicated working groups are being formed to:</p> <ul data-spread="false"> <li> <p><strong>Group 1:</strong> Identify roadblocks faced by exchanges, brokers, and market participants</p> </li> <li> <p><strong>Group 2:</strong> Address pain points raised by Farmer Producer Organizations (FPOs)</p> </li> </ul> <p>This move follows a stakeholder meeting on <strong>July 1, 2025</strong>, chaired by SEBI Chairman <strong>Tuhin Kanta Pandey</strong>, which involved key players like exchanges, brokers, clearing corporations, and FPOs.</p> <h3><strong>C) What Are Stakeholders Demanding?</strong></h3> <ul data-spread="false"> <li> <p><strong>FPO Issues:</strong> Difficulty in trading mustard, guar, gram, and turmeric</p> </li> <li> <p><strong>Exchange Requests:</strong> Update outdated compliance regulations</p> </li> <li> <p><strong>Policy Reboot:</strong> Reinstate the <strong>CDMRD</strong> (Commodities Market Regulation Department), which was merged with SEBI’s main regulatory wing in 2021</p> </li> </ul> <p>These issues have created operational friction for NCDEX, further stalling any significant innovation or product expansion.</p> <h3><strong>D) Are Bans on Agri-Commodities a Temporary Setback or Long-Term Risk?</strong></h3> <p>Currently, <strong>seven major agri-commodities remain under trading suspension</strong>—including paddy, wheat, mustard seed, and soybean. These bans, first imposed in <strong>December 2021</strong>, have now been extended until <strong>March 2026</strong>.</p> <p>While the official rationale has not been disclosed, inflationary pressure is believed to be the core reason. This policy overhang continues to restrict NCDEX’s volume and credibility as a full-service commodity exchange.</p> <p><br /><strong>Why It Matters for NCDEX Investors in Unlisted Market:</strong></p> <ul data-spread="false"> <li> <p><strong>Regulatory clarity</strong> could drive a swift rebound in trading volumes</p> </li> <li> <p><strong>Reinstatement of CDMRD</strong> may revive product launches and innovation</p> </li> <li> <p><strong>Lifting of bans</strong> could drastically improve NCDEX’s operational performance</p> </li> </ul> <h3><strong>E) What New Growth Areas Are Being Overlooked?</strong></h3> <p>There’s a large, untapped segment of <strong>non-agri derivatives</strong> that could diversify India’s commodity market:</p> <ul data-spread="false"> <li> <p><strong>Industrial commodities</strong> like cement, timber, diesel, bitumen</p> </li> <li> <p><strong>Freight and logistics derivatives</strong></p> </li> <li> <p><strong>Energy and electricity futures</strong> (recently approved)</p> </li> </ul> <p>However, roadblocks such as <strong>poor investor awareness</strong>, <strong>lack of research data</strong>, and <strong>sub-par mobile trading apps</strong> have kept participation low.</p> <p>As per SCRA regulations, SEBI has approved <strong>104 commodities</strong> for trading, yet only a few are actively traded. A renewed policy push could open doors for NCDEX to expand into these new segments.</p> <h3><strong>F) Are Market Participants Optimistic About the Reforms?</strong></h3> <p>Yes. Industry sentiment after the July 1 meeting has been positive. <strong>Rakesh Jain</strong>, President of <strong>Commodity Participants Association of India (CPAI)</strong>, praised the discussions as “inclusive and engaging,” and expects a “robust roadmap” to emerge soon.</p> <p>Meanwhile, industry insiders are planning:</p> <ul data-spread="false"> <li> <p>A new <strong>impact assessment study</strong> on agri-commodity bans</p> </li> <li> <p>A formal <strong>policy presentation to SEBI and the government</strong></p> </li> </ul> <h3><strong>G) What Does This Mean for NCDEX’s Unlisted Shareholders?</strong></h3> <p>SEBI’s reformative steps and inclusive consultations may lay the foundation for:</p> <ul data-spread="false"> <li> <p><strong>Higher trading volumes</strong> post-ban reversal</p> </li> <li> <p><strong>Product diversification</strong> beyond agri</p> </li> <li> <p><strong>Renewed investor confidence</strong> in NCDEX</p> </li> </ul> <p>For investors in the <strong>unlisted shares of NCDEX</strong>, these moves could act as strong valuation triggers, especially as the company positions itself for a potential IPO in the near future.</p> <h2><strong>Conclusion: Can SEBI’s Reset Recharge NCDEX's Growth Story?</strong></h2> <p>India’s agri-derivatives market is at a decisive inflection point. SEBI’s structured reforms and stakeholder engagement offer a promising start—but execution will be key.</p> <p>If the proposed changes unlock trading activity, resolve policy bottlenecks, and broaden the commodity spectrum, <strong>NCDEX could emerge stronger than ever—making its unlisted stock a potential value play.</strong></p> <h3><strong>Disclaimer:</strong></h3> <p>UnlistedZone is not a SEBI-registered Research Analyst or Investment Advisor.All information shared on our platform—including articles, posts, investment insights, and price trends—is solely for educational and informational purposes. We do not provide any buy/sell recommendations or financial advice.Investors are advised to do their own due diligence or consult a SEBI-registered advisor before making any investment decisions. Investments in unlisted and pre-IPO shares are subject to market risks, including liquidity risk and price volatility.UnlistedZone does not guarantee any returns and shall not be held liable for any losses incurred as a result of investment decisions taken based on the information provided.</p>
Indicative prices, company research and your enquiries — in your pocket. Get price notes on the names you follow and reach our team from anywhere.
